GlaxoSmithKline Pharma A/S - αποτελεσματα

zantac 150 mg brusetabletter

glaxosmithkline pharma a/s - ranitidinhydrochlorid - brusetabletter - 150 mg

zantac 300 mg brusetabletter

glaxosmithkline pharma a/s - ranitidinhydrochlorid - brusetabletter - 300 mg

clopidogrel "gsk" 75 mg filmovertrukne tabletter

glaxosmithkline pharma a/s - clopidogrelhydrogensulfat - filmovertrukne tabletter - 75 mg

dermovat 0,5 mg/g creme

glaxosmithkline pharma a/s - clobetasolpropionat - creme - 0,5 mg/g

imigran sprint 50 mg dispergible tabletter

glaxosmithkline pharma a/s - sumatriptansuccinat - dispergible tabletter - 50 mg

lamictal 2 mg tyggetabletter/dispergible tabletter

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 2 mg

lamictal 25 mg tabletter

glaxosmithkline pharma a/s - lamotrigin - tabletter - 25 mg

malarone 25+62,5 mg filmovertrukne tabletter

glaxosmithkline pharma a/s - atovaquon, proguanilhydrochlorid - filmovertrukne tabletter - 25+62,5 mg

relenza 5 mg inhalationspulver, afdelt

glaxosmithkline pharma a/s - zanamivir - inhalationspulver, afdelt - 5 mg

seretide 50+100 mikrog./dosis inhalationspulver, afdelt

glaxosmithkline pharma a/s - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+100 mikrog./dosis